AIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend

Bulletin Express

08/12

AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026.

The agenda includes:

1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.

2. Considering a recommendation for the payment of an interim dividend, if any.

3. Addressing other routine business matters.

The meeting will be chaired by Chairman and CEO Mr. Yan Zhou. The Board currently comprises six executive directors, one non-executive director and four independent non-executive directors.

The notice was released in Hong Kong on 12 August 2026. Stakeholders can expect publication of the interim results following Board approval.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1117327391"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117327391\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117327391?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117327391","market":"hk","top_or_hot":-1,"title":"AIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend","media":"Bulletin Express","content":"<p>AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026.</p>\n<p>The agenda includes:</p>\n<p>1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>2. Considering a recommendation for the payment of an interim dividend, if any.</p>\n<p>3. Addressing other routine business matters.</p>\n<p>The meeting will be chaired by Chairman and CEO Mr. Yan Zhou. The Board currently comprises six executive directors, one non-executive director and four independent non-executive directors.</p>\n<p>The notice was released in Hong Kong on 12 August 2026. Stakeholders can expect publication of the interim results following Board approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-12 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026.</p>\n<p>The agenda includes:</p>\n<p>1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>2. Considering a recommendation for the payment of an interim dividend, if any.</p>\n<p>3. Addressing other routine business matters.</p>\n<p>The meeting will be chaired by Chairman and CEO Mr. Yan Zhou. The Board currently comprises six executive directors, one non-executive director and four independent non-executive directors.</p>\n<p>The notice was released in Hong Kong on 12 August 2026. Stakeholders can expect publication of the interim results following Board approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06660","symbol_name":"艾美疫苗","start_time":0,"source_url":"","article_id":"1117327391","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117327391","pubTimestamp":1786530396,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026. The agenda includes: 1. Reviewing and approving the consolidated interim results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06660":"艾美疫苗"},"translate_title":"AIM Vaccine 计划于 2026 年 8 月 23 日召开董事会会议，批准 2026 年上半年中期业绩和潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06660":1},"content_text":"AIM Vaccine Co., Ltd. has notified shareholders that its Board of Directors will convene on Sunday, 23 August 2026.\nThe agenda includes:\n1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.\n2. Considering a recommendation for the payment of an interim dividend, if any.\n3. Addressing other routine business matters.\nThe meeting will be chaired by Chairman and CEO Mr. Yan Zhou. The Board currently comprises six executive directors, one non-executive director and four independent non-executive directors.\nThe notice was released in Hong Kong on 12 August 2026. Stakeholders can expect publication of the interim results following Board approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}